These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 35084549)

  • 1. Single-cell transcriptome profiling reveals intra-tumoral heterogeneity in human chordomas.
    Duan W; Zhang B; Li X; Chen W; Jia S; Xin Z; Jian Q; Jian F; Chou D; Chen Z
    Cancer Immunol Immunother; 2022 Sep; 71(9):2185-2195. PubMed ID: 35084549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unravelling the role of immune cells and FN1 in the recurrence and therapeutic process of skull base chordoma.
    Huo X; Ma S; Wang C; Song L; Yao B; Zhu S; Li P; Wang L; Wu Z; Wang K
    Clin Transl Med; 2023 Oct; 13(10):e1429. PubMed ID: 37784253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multimodal profiling of chordoma immunity reveals distinct immune contextures.
    van Oost S; Meijer DM; Ijsselsteijn ME; Roelands JP; van den Akker BEMW; van der Breggen R; Briaire-de Bruijn IH; van der Ploeg M; Wijers-Koster PM; Polak SB; Peul WC; van der Wal RJP; de Miranda NFCC; Bovee JVMG
    J Immunother Cancer; 2024 Jan; 12(1):. PubMed ID: 38272563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single-cell sequencing reveals VEGFR as a potential target for CAR-T cell therapy in chordoma.
    Wu H; Li X; Zhang B; Liu P; Qi M; Du Y; Zhang C; Duan W; Chen Z
    Br J Cancer; 2024 Jun; 130(10):1609-1620. PubMed ID: 38605247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Matrix gene expression analysis and cellular phenotyping in chordoma reveals focal differentiation pattern of neoplastic cells mimicking nucleus pulposus development.
    Gottschalk D; Fehn M; Patt S; Saeger W; Kirchner T; Aigner T
    Am J Pathol; 2001 May; 158(5):1571-8. PubMed ID: 11337353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular features and vulnerabilities of recurrent chordomas.
    Seeling C; Lechel A; Svinarenko M; Möller P; Barth TFE; Mellert K
    J Exp Clin Cancer Res; 2021 Jul; 40(1):244. PubMed ID: 34330313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genome-wide DNA methylation profiling of recurrent and non-recurrent chordomas.
    Alholle A; Brini AT; Bauer J; Gharanei S; Niada S; Slater A; Gentle D; Maher ER; Jeys L; Grimer R; Sumathi VP; Latif F
    Epigenetics; 2015; 10(3):213-20. PubMed ID: 25621392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA methylation, combined with RNA sequencing, provide novel insight into molecular classification of chordomas and their microenvironment.
    Baluszek S; Kober P; Rusetska N; Wągrodzki M; Mandat T; Kunicki J; Bujko M
    Acta Neuropathol Commun; 2023 Jul; 11(1):113. PubMed ID: 37434245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leukemia Inhibitory Factor Promotes Aggressiveness of Chordoma.
    Gulluoglu S; Sahin M; Tuysuz EC; Yaltirik CK; Kuskucu A; Ozkan F; Sahin F; Ture U; Bayrak OF
    Oncol Res; 2017 Aug; 25(7):1177-1188. PubMed ID: 28247842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of cancer stem-like cells in chordoma.
    Aydemir E; Bayrak OF; Sahin F; Atalay B; Kose GT; Ozen M; Sevli S; Dalan AB; Yalvac ME; Dogruluk T; Türe U
    J Neurosurg; 2012 Apr; 116(4):810-20. PubMed ID: 22283189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PD-1, PD-L1, PD-L2 expression in the chordoma microenvironment.
    Mathios D; Ruzevick J; Jackson CM; Xu H; Shah SR; Taube JM; Burger PC; McCarthy EF; Quinones-Hinojosa A; Pardoll DM; Lim M
    J Neurooncol; 2015 Jan; 121(2):251-9. PubMed ID: 25349132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HOXA7, HOXA9, and HOXA10 are differentially expressed in clival and sacral chordomas.
    Jäger D; Barth TFE; Brüderlein S; Scheuerle A; Rinner B; von Witzleben A; Lechel A; Meyer P; Mayer-Steinacker R; Baer AV; Schultheiss M; Wirtz CR; Möller P; Mellert K
    Sci Rep; 2017 May; 7(1):2032. PubMed ID: 28515451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA expression profiling reveals the potential function of microRNA-31 in chordomas.
    Bayrak OF; Gulluoglu S; Aydemir E; Ture U; Acar H; Atalay B; Demir Z; Sevli S; Creighton CJ; Ittmann M; Sahin F; Ozen M
    J Neurooncol; 2013 Nov; 115(2):143-51. PubMed ID: 23912551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of E-cadherin in chordomas: diagnostic marker and possible role of tumor cell affinity.
    Mori K; Chano T; Kushima R; Hukuda S; Okabe H
    Virchows Arch; 2002 Feb; 440(2):123-127. PubMed ID: 11964040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single-cell transcriptomic analysis of tumor heterogeneity and intercellular networks in human urothelial carcinoma.
    Jin X; Wang Q; Luo F; Pan J; Lu T; Zhao Y; Zhang X; Xiang E; Zhou C; Huang B; Lu G; Chen P; Shao Y
    Chin Med J (Engl); 2023 Mar; 136(6):690-706. PubMed ID: 36939254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chordoma and chondrosarcoma gene profile: implications for immunotherapy.
    Schwab JH; Boland PJ; Agaram NP; Socci ND; Guo T; O'Toole GC; Wang X; Ostroumov E; Hunter CJ; Block JA; Doty S; Ferrone S; Healey JH; Antonescu CR
    Cancer Immunol Immunother; 2009 Mar; 58(3):339-49. PubMed ID: 18641983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical investigation of chordomas: histogenetic and differential diagnostic aspects.
    Bouropoulou V; Bosse A; Roessner A; Vollmer E; Edel G; Wuisman P; Härle A
    Curr Top Pathol; 1989; 80():183-203. PubMed ID: 2776494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of epidermal growth factor receptor in chordoma pathogenesis: a potential therapeutic target.
    Shalaby A; Presneau N; Ye H; Halai D; Berisha F; Idowu B; Leithner A; Liegl B; Briggs TR; Bacsi K; Kindblom LG; Athanasou N; Amary MF; Hogendoorn PC; Tirabosco R; Flanagan AM
    J Pathol; 2011 Feb; 223(3):336-46. PubMed ID: 21171079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chordoma: the nonsarcoma primary bone tumor.
    Chugh R; Tawbi H; Lucas DR; Biermann JS; Schuetze SM; Baker LH
    Oncologist; 2007 Nov; 12(11):1344-50. PubMed ID: 18055855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcriptome comparison identifies potential biomarkers of spine and skull base chordomas.
    Bell AH; DeMonte F; Raza SM; Rhines LD; Tatsui CE; Prieto VG; Fuller GN; Bell D
    Virchows Arch; 2018 Mar; 472(3):489-497. PubMed ID: 28844110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.